Luciana Borio

Luciana Borio

Director/Board Member presso EAGLE PHARMACEUTICALS, INC.

Patrimonio netto: 390 449 $ in data 31/03/2024

53 anni
Finance
Health Technology
Consumer Services

Profilo

Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners.
In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs.
Dr. Borio is a specialist in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.
Prior to joining ARCH, she was a senior vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to deliver innovative technology solutions to support the missions of the U.S.
Intelligence Community.
Past positions include serving as a member of President Biden’s transition COVID-19 Advisory Board and Director for Medical and Biodefense Preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America’s influenza vaccines.
Prior to that, she was the Acting Chief Scientist of the U.S.
Food and Drug Administration (2015-2017) and the Assistant Commissioner for Counterterrorism Policy of the FDA (2010-2017).
Dr. Borio is an adjunct Assistant Professor of Medicine at Johns Hopkins University (2003-present), where she continues to practice medicine part-time.
She is also a senior fellow for global health at the Council on Foreign Relations.
Dr. Borio obtained her M.D.
from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
26/03/2024 2 278 ( 0.00% ) 390 449 $ 31/03/2024
31/03/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Luciana Borio

SocietàPosizioneInizio
EAGLE PHARMACEUTICALS, INC. Director/Board Member 28/04/2021
INSULET CORPORATION Director/Board Member 18/10/2021
Director/Board Member 25/10/2021
Private Equity Investor 01/12/2021
Director/Board Member -
Tutte le posizioni attive di Luciana Borio

Precedenti posizioni note di Luciana Borio

SocietàPosizioneFine
Corporate Officer/Principal 01/01/2020
National Security Council Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal 01/10/2008
Vedi nel dettaglio l'esperienza di Luciana Borio

Formazione di Luciana Borio

George Washington University Undergraduate Degree
George Washington University School of Medicine & Health Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Luciana Borio

Relazioni

100 +

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
EAGLE PHARMACEUTICALS, INC.

Health Technology

INSULET CORPORATION

Health Technology

Aziende private7

Finance

Commercial Services

Government

Finance

National Security Council

Technology Services

Commercial Services

Vedi le connessioni aziendali